Clinical Trials Browser

Active not recruiting × Gliosarcoma × pembrolizumab × Clear all

NCT02337686 2025-08-15

Pembrolizumab in Treating Patients With Recurrent Glioblastoma

Phase 2 Active not recruiting

18 enrolled 12 charts

Glioblastoma, Gliosarcoma

NCT03197506 2025-04-06

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Phase 2 Active not recruiting

Glioblastoma, Gliosarcoma